Table 1. Samples included in this study... | American Society of Hematology

Table 1.

Samples included in this study

Sample	Description	Notes
N1	20-y-old female	Healthy individual
N2	21-y-old male	Healthy individual
N3	51-y-old female	Healthy individual
N4	31-y-old female	Healthy individual
N5	62-y-old male	Healthy individual
N6	46-y-old female	Healthy individual
N7	39-y-old male	Healthy individual
D1	24-y-old female,	DBA, RPS19 L18P mutation, steroid nonresponsive, and transfusion dependent. Patient #DBA1³
D1.2	second sample at 27 y old
D2	47-y-old female	DBA, no identified mutation, steroid responsive but not tolerated, and transfusion dependent. Index patient²⁹
M1	73-y-old male	MDS-5q, 5q13-q33 deletion; 74.5% of cells have the 5q^– via iFISH. No cytogenetic abnormality besides del(5q)
M2	61-y-old female	MDS-5q, 5q13-q33 deletion; 65% of cells have the 5q^– via iFISH. No cytogenetic abnormality besides del(5q). Patient #MDS1³

Sample	Description	Notes
N1	20-y-old female	Healthy individual
N2	21-y-old male	Healthy individual
N3	51-y-old female	Healthy individual
N4	31-y-old female	Healthy individual
N5	62-y-old male	Healthy individual
N6	46-y-old female	Healthy individual
N7	39-y-old male	Healthy individual
D1	24-y-old female,	DBA, RPS19 L18P mutation, steroid nonresponsive, and transfusion dependent. Patient #DBA1³
D1.2	second sample at 27 y old
D2	47-y-old female	DBA, no identified mutation, steroid responsive but not tolerated, and transfusion dependent. Index patient²⁹
M1	73-y-old male	MDS-5q, 5q13-q33 deletion; 74.5% of cells have the 5q^– via iFISH. No cytogenetic abnormality besides del(5q)
M2	61-y-old female	MDS-5q, 5q13-q33 deletion; 65% of cells have the 5q^– via iFISH. No cytogenetic abnormality besides del(5q). Patient #MDS1³